Publications To Date

    NANOSTRING PUBLICATIONS

    Filter Publications

    PAGE 66 OF 78 | DISPLAYING 976 - 990 OF 1170 RESULTS

    Liu S. et al., Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial., [Epub ahead of print]., Breast Cancer Res. and Treat, Jan 01, 2015

    Andrade V.P. et al., Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion., [Epub ahead of print]., Mol. Oncol., Dec 24, 2014

    Park Y-H. et al., A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgery., [Epub ahead of print]., Int. J. Cancer, Dec 24, 2014

    Navari M. et al., Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus., [Epub ahead of time]., Front Microb., Dec 23, 2014

    Isayeva T. et al., The protective effect of p16INK4a in oral cavity carcinomas: p16Ink4A dampens tumor invasion integrated analysis of expression and kinomics pathways., [Epub ahead of print]., Mod. Pathol., Dec 19, 2014

    Asnaghi L. et al., Identification of Multiple DNA Copy Number Alterations Including Frequent 8p11.22 Amplification in Conjunctival Squamous Cell Carcinoma., , IOVS, Dec 09, 2014

    Manier S. et al., Prognostic Value of Circulating Exosomal microRNAs in 112 Patients with Multiple Myeloma., [Epub ahead of print], Blood, Dec 09, 2014

    Kim S-T. et al., The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer., [Epub ahead of print]., Clin. Trans.Oncol, Dec 02, 2014

    Kim H.S. et al., Phase II Clinical and Exploratory Biomarker Study of Dacomitinib in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck., [Epub ahead of print]., Clin. Cancer Res., Nov 24, 2014

    Duran C.E. et al., Mechanisms of Resistance to Cabazitaxel., [Epub ahead of print]., Mol. Cancer Ther., Nov 21, 2014

    Montes De Oca R. et al., The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma., [Epub ahead of print]., Molecular Oncology, Nov 20, 2014

    Akhter A. et al., Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system., [Epub ahead of print]., J. Neuro-Oncol, Nov 13, 2014

    Bailey S.T. et al., Loss estrogen-regulated microRNA expression increases HER2 signaling and is prognostic of poor outcome in luminal breast cancer., [Epub ahead of print]., Cancer Res., Nov 11, 2014

    Carey C.D. et al., Molecular Classification of MYC-Driven B-Cell Lymphomas by Targeted Gene Expression Profiling of Fixed Biopsy Specimens., [Epub ahead of print]., J. Mol. Diag., Nov 07, 2014

    Nevo I. et al., Identification of Molecular Pathways Facilitating Glioma Cell Invasion In Situ., [Epub ahead of print]., PLoS ONE, Nov 03, 2014